Predicting Biotech Breakouts Before They Happen

On July 1st, 2025, we screened 640 biotech companies for signals that often come before major price movement. Ranking tickers was our first step in forecasting the initial sample of 124 (20%).

Each flag represents a measurable change in fundamentals that may indicate an emerging catalyst. Companies are ranked by how many of these indicators they’ve triggered. This process allows us to focus on the most obviously promising candidates for deeper analysis and prediction.

ScanScor’s Biomed Prediction Engine (BPE)—is a proprietary tool powered by AI and continuously refreshed data. We compress relevant data into finely tuned prompts for Orbo, our custom-trained AI model, which generates forward-looking predictions.

Predictions are updated as new data and catalysts emerge. Visit this page regularly to view Orbo’s successful forecasts, and join ScanScor for early access to approaching catalyst windows and high-potential breakout candidates.